secwatch.observer — SEC 8-K summary
======================================

Issuer:     FinTrade Sherpa, Inc. (FTSP)
CIK:        0001319643
Form:       8-K
Filed at:   2022-01-03T23:59:59+00:00
Accession:  0001199835-21-000793
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lode-Star Mining acquires patented EGCG molecule assets from Sapir Pharmaceuticals for $1M in preferred stock
--------------------------------------------------------------------------------

- Acquired all assets related to stabilized EGCG molecule for pharmaceutical development.
- Consideration: 1,000,000 Series A Convertible Preferred shares valued at $1.00 each, convertible to common at 450:1.
- Sapir receives 5% royalty on gross revenues from licensed or derived products; paid quarterly for 5 years, extendable.
- Sapir gets 450 votes per preferred share; restrictions on reverse splits and new preferred issuance for one year.
- Transaction closed Dec 28, 2021; press release issued Dec 30, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1319643/000119983521000793/0001199835-21-000793-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1319643/000119983521000793/lsmg_8k.htm
  HTML page:      https://secwatch.observer/filing/0001199835-21-000793

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer